Latest Posts
About This Stock
More About This Stock
Read
Read
Read
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus
Article By:
Benzinga
Sunday, December 26, 2021 2:45 PM EDT
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key biopharma catalysts for the unfolding week.
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Article By:
Benzinga
Sunday, November 29, 2020 4:14 PM EDT
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the Thanksgiving holiday. The week kickstarted with lukewarm news on the coronavirus vaccine front.
Attention Biotech Investors: Mark Your Calendar For Dec. PDUFA Dates
Article By:
Benzinga
Saturday, November 28, 2020 3:50 PM EDT
The U.S. Food and Drug Administration's approval machinery churned out a lot of disappointments in November. Most of the negative verdicts were tied to difficulties the agency had in inspecting facilities where drugs are being manufactured.
